MedTrace Logo

OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)

NCT06003634 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-03-25

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are:

* Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management?
* If effective, which facets of the peer model are most effective? Peer coaches will
* Undergo peer coach training.
* Reach out to peer participants on a weekly/biweekly time frame to discuss self-management and goal setting.
* Retain records of contact, topics discussed, and general notes on interactions. Researchers will compare differences in the frequency of contact, as well as how peer coaches were matched to peer participants to see if efficacy of the intervention is altered between groups.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Peer Coaching - Peer Participants A

Peer participants in group A will self select a peer coach and will be contacted weekly by peer coaches.

BEHAVIORAL

Peer Coaching - Peer Participants B

Peer participants in group B will self select a peer coach and will be contacted bi-weekly by peer coaches.

BEHAVIORAL

Peer Coaching - Peer Participants C

Peer participants in group C will be matched with a peer coach and will be contacted weekly by peer coaches.

BEHAVIORAL

Peer Coaching - Peer Participants D

Peer participants in group D will be matched with a peer coach and will be contacted bi-weekly by peer coaches.

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Brittany L Smalls

    lead OTHER

Principal Investigators

  • Brittany L Smalls, PhD · University of Kentucky

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-20
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06003634 on ClinicalTrials.gov